Cibc Private Wealth Group, LLC Arrowhead Pharmaceuticals, Inc. Transaction History

Cibc Private Wealth Group, LLC

$50.1 Billion
Q1 2024

A detailed history of Cibc Private Wealth Group, LLC transactions in Arrowhead Pharmaceuticals, Inc. stock. As of the latest transaction made, Cibc Private Wealth Group, LLC holds 1,100 shares of ARWR stock, worth $27,577. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,100

Holding current value

$27,577

% of portfolio

0.0%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	BUY	$27.21 - $39.48 $29,931 - $43,428	1,100 New	1,100 $31,000
Q2 2021 Aug 16, 2021	SELL	$62.15 - $90.32 $631,381 - $917,560	-10,159 Closed	0 $0
Q1 2021 May 12, 2021	SELL	$61.35 - $90.47 $43,129 - $63,600	-703 Reduced 6.47%	10,159 $674,000
Q4 2020 Feb 12, 2021	SELL	$43.82 - $85.37 $12,576 - $24,501	-287 Reduced 2.57%	10,862 $834,000
Q3 2020 Nov 03, 2020	BUY	$33.21 - $51.27 $370,258 - $571,609	11,149 New	11,149 $480,000

Q3 2020 Oct 29, 2020	SELL	$33.21 - $51.27 $370,258 - $571,609	-11,149 Closed	0 $0
Q2 2020 Aug 13, 2020	SELL	$26.12 - $43.27 $927,808 - $1.54 Million	-35,521 Reduced 76.11%	11,149 $482,000
Q1 2020 May 15, 2020	BUY	$20.56 - $63.12 $729,756 - $2.24 Million	35,494 Added 317.59%	46,670 $1.34 Million
Q4 2019 Jan 30, 2020	SELL	$28.14 - $73.01 $1,997 - $5,183	-71 Reduced 0.63%	11,176 $709,000
Q3 2019 Oct 16, 2019	SELL	$26.26 - $34.86 $2.64 Million - $3.5 Million	-100,375 Reduced 89.92%	11,247 $317,000
Q2 2019 Jul 31, 2019	SELL	$17.43 - $28.82 $19,190 - $31,730	-1,101 Reduced 0.98%	111,622 $2.96 Million
Q1 2019 May 10, 2019	SELL	$12.05 - $20.18 $17,315 - $28,998	-1,437 Reduced 1.26%	112,723 $2.07 Million
Q4 2018 Feb 05, 2019	BUY	$10.74 - $19.7 $366,878 - $672,952	34,160 Added 42.7%	114,160 $1.42 Million
Q2 2018 Aug 02, 2018	BUY	$6.37 - $14.02 $509,600 - $1.12 Million	80,000 New	80,000 $1.09 Million

Others Institutions Holding ARWR

# of Institutions

296

Shares Held

88.5M

Call Options Held

905K

Put Options Held

387K

View Full List

About ARROWHEAD PHARMACEUTICALS, INC.

Ticker ARWR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 105,849,000
Market Cap $2.65B
Description
Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, w...

More about ARWR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cibc Private Wealth Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cibc Private Wealth Group, LLC with notifications on news.

Account

Cibc Private Wealth Group, LLC Arrowhead Pharmaceuticals, Inc. Transaction History